These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1965910)

  • 21. rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats.
    Wang S; Jiang J; Wang Y; Jia Q; Dai S; Wang Y; Lv L; Wang J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):240-245. PubMed ID: 29407168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction.
    Dorn GW; Liel N; Trask JL; Mais DE; Assey ME; Halushka PV
    Circulation; 1990 Jan; 81(1):212-8. PubMed ID: 2137044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
    Schwemmer M; Sommer O; Bassenge E
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):301-7. PubMed ID: 11800413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.
    Viinikka L; Toivanen J; Ylikorkala O
    Br J Clin Pharmacol; 1982 Sep; 14(3):456-8. PubMed ID: 6812610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.
    Levin RI; Weksler BB; Jaffe EA
    Circulation; 1982 Dec; 66(6):1299-307. PubMed ID: 6291803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W
    J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of captopril on platelet cytosolic [Ca2+]i and plasma TXA2/PGI2 in renovascular hypertensive rats].
    Wei XR; Hu L; Du J
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):89-91. PubMed ID: 10375769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Manrique RV; Manrique V
    Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of yi qi tong mai oral liquid on acute myocardial ischemia in dogs].
    Chen J; Cai S; Li S; Feng Y; Xie R
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):171-3. PubMed ID: 12212050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
    Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective Effects of Baicalin on Experimental Myocardial Infarction in Rats.
    Wang L; Li Y; Lin S; Pu Z; Li H; Tang Z
    Braz J Cardiovasc Surg; 2018; 33(4):384-390. PubMed ID: 30184036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction.
    Romson JL; Hook BG; Rigot VH; Schork MA; Swanson DP; Lucchesi BR
    Circulation; 1982 Nov; 66(5):1002-11. PubMed ID: 7127687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.